Videocast and Testimony: The Role of the National Institute of Allergy and Infectious Diseases in Research to Address the COVID-19 Pandemic. Senate Committee on Health, Education, Labor, and Pensions hearing: “The Path Forward: A Federal Perspective on the COVID-19 Response.”
Anthony S. Fauci, M.D., NIAID Director
Dr. Fauci was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria as well as emerging diseases such as Ebola and Zika. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. The NIAID budget for fiscal year 2021 is an estimated $6.1 billion.
Dr. Fauci has advised seven Presidents on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.
Read about how NIAID is conducting and supporting research on SARS CoV-2 and the disease COVID-19
NIAID Director Anthony S. Fauci, M.D.
Credit:
NIAID